UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT
PURSUANT TO SECTION 14(d)(4) OF THE
SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
VENTANA MEDICAL SYSTEMS, INC.
(Name of Subject Company)
VENTANA MEDICAL SYSTEMS, INC.
(Name of Person Filing Statement)
Common Stock, Par Value $0.001 Per Share
(Title of Class of Securities)
92276H106
(CUSIP Number of Class of Securities)
Christopher M. Gleeson
President and Chief Executive Officer
VENTANA MEDICAL SYSTEMS, INC.
1910 E. Innovation Park Dr.
Tucson, AZ 85755
Telephone (520) 887-2155
Toll Free (800) 227-2155
Fax (520) 229-4207
(Name, Address and Telephone Number of Person Authorized to Receive Notice and Communications on Behalf of the Person Filing Statement)
COPIES TO:
Thomas A. Cole Fredrick C. Lowinger Michael A. Gordon Robert L. Verigan Sidley Austin LLP 1 South Dearborn Street Chicago, IL 60603 Telephone (312) 853-7000 Fax (312) 853-7036 |
Daniel M. Mahoney Snell & Wilmer L.L.P. One Arizona Center 400 E. Van Buren Phoenix, AZ 85004 Telephone (602) 382-6000 Fax (602) 382-6070 |
¨ | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer |
Purpose of Amendment
The purpose of this amendment is to amend Item 9 Exhibits by adding a new exhibit (a)(5) and revising the Exhibit Index accordingly.
Item 9. Materials to Be Filed as Exhibits.
Exhibit No. | Document | |
(a)(1) | Letter to the Companys stockholders dated July 11, 2007*(1) | |
(a)(2) | Press release issued by the Company on July 11, 2007(1) | |
(a)(3) | Letter to the Companys employees dated July 11, 2007(1) | |
(a)(4) | Employee/customer/supplier Frequently Asked Questions (1) | |
(a)(5) | Press release issued by the Company on July 19, 2007 | |
(e)(1) | Excerpts from the Companys Definitive Proxy Statement on Schedule 14A relating to the 2007 Annual Meeting of Stockholders as filed with the SEC on March 28, 2007(1) | |
(e)(2) | 1988 Stock Option Plan and forms of agreements thereunder (Incorporated by reference to Exhibit 10.7(A) to the Companys Registration Statement on Form S-l (SEC File No. 333-4461), declared effective by the SEC July 26, 1996) | |
(e)(3) | 1996 Stock Option Plan and forms of agreements thereunder (Incorporated by reference to Exhibit 10.7(B) to the Companys Registration Statement on Form S-l (SEC File No. 333-4461), declared effective by the SEC July 26, 1996) | |
(e)(4) | 1996 Employee Stock Purchase Plan (Incorporated by reference to Exhibit 10.8(B) to the Companys Registration Statement on Form S-l (SEC File No. 333-4461), declared effective by the SEC July 26, 1996) | |
(e)(5) | 1996 Directors Option Plan (Incorporated by reference to Exhibit 10.8(C) to the Companys Registration Statement on Form S-l (SEC File No. 333-4461), declared effective by the SEC July 26, 1996) | |
(e)(6) | 1998 Nonstatutory Stock Option Plan and forms of agreements thereunder (Incorporated by reference to Exhibit 4.1 to the Companys Registration Statement on Form S-8 (SEC File No. 333-92883), filed with the SEC on December 16, 1999 and Exhibit 4.1 to the Companys Registration Statement on Form S-8 (SEC File No. 333-105976), filed with the SEC on June 10, 2003) | |
(e)(7) | 2001 Outside Director Stock Option Plan (Incorporated by reference to Exhibit 4.1 to the Companys Registration Statement on Form S-8 (SEC File No. 333-69658), filed with the SEC on September 19, 2001) | |
(e)(8) | 2005 Equity Incentive Plan (Incorporated by reference to the Companys Definitive Proxy Statement on Schedule 14A (SEC File No. 000-20931) filed with the SEC on March 31, 2005) | |
(e)(9) | 2005 Employee Stock Purchase Plan (Incorporated by reference to the Companys Definitive Proxy Statement on Schedule 14A (SEC File No. 000-20931) filed with the SEC on March 31, 2005) |
2
(e)(10) | 2005 Equity Incentive Plan Agreement (Incorporated by reference to Exhibit 10.8.1 to the Companys Annual Report on Form 10-K (SEC File No. 000-20931) filed with the SEC on February 16, 2007) | |
(e)(11) | 2005 Equity Incentive Plan Agreement (Accelerated Vesting) (Incorporated by reference to Exhibit 10.8.2 to the Companys Annual Report on Form 10-K (SEC File No. 000-20931) filed with the SEC on February 16, 2007) | |
(e)(12) | Preferred Share Rights Agreement, dated as of May 6, 1998 between the Company and Norwest Bank Minnesota, N.A., including the Certificate of Designations, the form of Rights Certificate and the Summary of Rights attached thereto as Exhibits A, B and C, respectively (Incorporated by reference to Exhibit 1 to the Companys Registration Statement on Form 8-A12G filed with the SEC on June 9, 1998) | |
(e)(13) | Restated Certificate of Incorporation of the Company (Incorporated by reference to Exhibit 3.1(i)(a) to the Companys Registration Statement on Form S-l (SEC File No. 333-4461), declared effective by the SEC July 26, 1996) | |
(e)(14) | Certificate of Amendment to Certificate of Incorporation (Incorporated by reference to Exhibit 3.3 to the Companys Quarterly Report on Form 10-Q (SEC File No. 000-20931), filed with the SEC on July 26, 2005) | |
(e)(15) | Form of Indemnification Agreement for directors and officers (Incorporated by reference to Exhibit 10.6 to the Companys Registration Statement on Form S-l (SEC File No. 333-4461), declared effective by the SEC July 26, 1996) |
* | Included in materials mailed to the Companys stockholders. |
(1) |
Previously filed with Schedule 14D-9 or an amendment thereto. |
3
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct.
VENTANA MEDICAL SYSTEMS, INC. | ||
By: | /s/ Christopher M. Gleeson | |
Christopher M. Gleeson President and Chief Executive Officer
Date: July 19, 2007 |